Q2936330 (Q2936330): Difference between revisions
From MaRDI portal
Changed an Item |
Set profile property. |
||
| (5 intermediate revisions by one other user not shown) | |||
| Property / describes a project that uses | |||
| Property / describes a project that uses: R / rank | |||
Normal rank | |||
| Property / describes a project that uses | |||
| Property / describes a project that uses: mvtnorm / rank | |||
Normal rank | |||
| Property / describes a project that uses | |||
| Property / describes a project that uses: gMCP / rank | |||
Normal rank | |||
| Property / describes a project that uses | |||
| Property / describes a project that uses: WinBUGS / rank | |||
Normal rank | |||
| Property / describes a project that uses | |||
| Property / describes a project that uses: SAS / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Latest revision as of 10:05, 5 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
scientific article |
Statements
15 December 2014
0 references
clinical trial design
0 references
phase II dose-ranging trials
0 references
escalation with overdose control
0 references
